Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
Data up to Jan 2025
Total Citations Per Year
Abstract
References (36)
“Mini-mental state”
1975 • 82,784 citations
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Practical Statistics for Medical Research
1990 • 9,667 citations
Frontotemporal lobar degeneration
1998 • 4,937 citations
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
1993 • 3,693 citations
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
1998 • 3,377 citations
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
1994 • 1,291 citations
Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values
1977 • 867 citations
Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values
1977 • 779 citations
tau protein in cerebrospinal fluid
1995 • 760 citations
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
1995 • 684 citations
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
1998 • 651 citations
Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay
1993 • 481 citations
Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF
1996 • 460 citations
Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan
1998 • 344 citations
WHITE MATTER LESIONS ON MAGNETIC RESONANCE IMAGING IN CLINICALLY DIAGNOSED ALZHEIMER'S DISEASE: EVIDENCE FOR HETEROGENEITY
1992 • 312 citations
Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease
1995 • 296 citations
Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
1999 • 167 citations
Cerebrospinal Fluid Tau Levels in Neurodegenerative Diseases with Distinct Tau-Related Pathology
1997 • 155 citations
Neurofilament protein levels in CSF are increased in dementia
1999 • 150 citations
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
1998 • 147 citations
The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimerʼs disease
1997 • 141 citations
Frequency oftau mutations in three series of non-Alzheimer's degenerative dementia
1999 • 137 citations
Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau
1995 • 128 citations
APOE is a major susceptibility gene for Alzheimer's disease
1994 • 102 citations
Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration
1998 • 95 citations
Tau Protein in Cerebrospinal Fluid
1998 • 83 citations
Differential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins
1996 • 82 citations
Protein Analyses in Cerebrospinal Fluid
1993 • 76 citations
Apolipoprotein E Interaction with the Neurofibrillary Tangles and Senile Plaques in Alzheimer Disease: Implications for Disease Pathogenesis
1995 • 73 citations
CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
1998 • 64 citations
Clinical Heterogeneity of Probable Alzheimer's Disease
1992 • 63 citations
Presence of parieto‐temporal symptomatology distinguishes early and late onset Alzheimer's disease
1991 • 49 citations
SYMPTOMATOLOGICAL CHARACTERISTICS DISTINGUISH BETWEEN FRONTOTEMPORAL DEMENTIA AND VASCULAR DEMENTIA WITH A DOMINANT FRONTAL LOBE SYNDROME
1997 • 42 citations
Molecular biology of brain aging and neurodegenerative disorders
1996 • 24 citations
[Genetic predisposition for Alzheimer's disease].
1995 • 3 citations